We developed a new system to classify the prognosis for ALL based on the promoter region SNPs present in the genes of the two key pro- and anti-apoptotic pathway regulators, the BAX and BCL2 genes. The gene discussed is BAX; the disease is acute lymphoblastic leukemia.